Free Trial

Jade Biosciences (JBIO) Institutional Ownership

Jade Biosciences logo
$8.86 +0.53 (+6.36%)
As of 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Jade Biosciences (NASDAQ:JBIO)

Number of
Institutional Buyers
(last 12 months)
22
Total
Institutional Inflows
(last 12 months)
$57.41M
Number of
Institutional Sellers
(last 12 months)
0
Get JBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Jade Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

JBIO Institutional Buying and Selling by Quarter

Jade Biosciences Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/26/2025Corient Private Wealth LLC10,133$101K0.0%N/A0.031%
8/15/2025Corient Private Wealth LLC10,133$101K0.0%N/A1.206%
8/15/2025Soleus Capital Management L.P.796,744$7.96M0.5%N/A94.850%
8/15/2025Sofinnova Investments Inc.107,391$1.07M0.1%N/A12.785%
8/15/2025Frazier Life Sciences Management L.P.1,772,116$17.70M0.7%N/A210.966%
8/15/2025BNP Paribas Financial Markets3,222$32K0.0%N/A0.384%
8/15/2025Bank of America Corp DE14,350$143K0.0%N/A1.708%
8/14/2025Orbimed Advisors LLC531,163$5.31M0.1%N/A63.159%
8/14/2025TCG Crossover Management LLC64,023$640K0.1%N/A7.613%
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.17,757$177K0.0%N/A2.111%
8/14/2025The Manufacturers Life Insurance Company 11,420$114K0.0%N/A1.358%
8/13/2025Affinity Asset Advisors LLC65,317$653K0.1%N/A7.776%
8/13/2025Russell Investments Group Ltd.3,143$31K0.0%N/A0.374%
8/12/2025XTX Topco Ltd25,752$257K0.0%N/A3.066%
8/12/2025Ameritas Investment Partners Inc.3,312$33K0.0%N/A0.394%
8/12/2025Rhumbline Advisers44,570$445K0.0%N/A5.306%
8/12/2025Legal & General Group Plc2,954$29K0.0%N/A0.352%
8/12/2025JPMorgan Chase & Co.15,367$154K0.0%N/A1.829%
8/11/2025Versant Venture Management LLC1,525,820$15.24M18.6%N/A181.429%
8/8/2025Intech Investment Management LLC22,995$230K0.0%N/A2.734%
8/8/2025Police & Firemen s Retirement System of New Jersey7,113$71K0.0%N/A0.846%
8/8/2025Geode Capital Management LLC676,431$6.76M0.0%N/A80.432%
7/18/2025Deltec Asset Management LLC15,756$157K0.0%N/A1.876%
(Data available from 1/1/2016 forward)

JBIO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of JBIO shares?

During the previous two years, 22 institutional investors and hedge funds held shares of Jade Biosciences. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($17.70M), Versant Venture Management LLC ($15.24M), Soleus Capital Management L.P. ($7.96M), Geode Capital Management LLC ($6.76M), Orbimed Advisors LLC ($5.31M), Sofinnova Investments Inc. ($1.07M), and Affinity Asset Advisors LLC ($653K).Learn more on Jade Biosciences' institutional investors.

Which institutional investors have been buying Jade Biosciences' stock?

Of the 22 institutional investors that purchased Jade Biosciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Frazier Life Sciences Management L.P. ($1.77M), Versant Venture Management LLC ($1.53M), Soleus Capital Management L.P. ($796.74K), Geode Capital Management LLC ($676.43K), Orbimed Advisors LLC ($531.16K), Sofinnova Investments Inc. ($107.39K), and Affinity Asset Advisors LLC ($65.32K).

How much institutional buying is happening at Jade Biosciences?

Institutional investors have bought a total of 5,746,982 shares in the last 24 months. This purchase volume represents approximately $57.41M in transactions.



This page (NASDAQ:JBIO) was last updated on 10/3/2025 by MarketBeat.com Staff
From Our Partners